Waters Corporation (WAT) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Waters Corporation stock (WAT) is currently trading at $302.32. Waters Corporation PE ratio is 28.10. Waters Corporation PS ratio (Price-to-Sales) is 9.37. Analyst consensus price target for WAT is $398.05. WallStSmart rates WAT as Hold.
- WAT PE ratio analysis and historical PE chart
- WAT PS ratio (Price-to-Sales) history and trend
- WAT intrinsic value — DCF, Graham Number, EPV models
- WAT stock price prediction 2025 2026 2027 2028 2029 2030
- WAT fair value vs current price
- WAT insider transactions and insider buying
- Is WAT undervalued or overvalued?
- Waters Corporation financial analysis — revenue, earnings, cash flow
- WAT Piotroski F-Score and Altman Z-Score
- WAT analyst price target and Smart Rating
Waters Corporation
📊 No data available
Try selecting a different time range
WAT Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Waters Corporation (WAT)
WAT trades 350% above its Graham fair value of $73.17, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Waters Corporation (WAT) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in market cap, peg ratio, return on equity. Concerns around price/sales and price/book. Fundamentals are solid but monitor weak areas for improvement.
Waters Corporation (WAT) Key Strengths (6)
Every $100 of shareholder equity generates $29 in profit
Keeps $34 of every $100 in revenue after operating costs
Keeps $20 of every $100 in revenue as net profit
Large-cap company with substantial market presence
Good growth relative to its price
60.74% held by institutions, strong professional interest
Supporting Valuation Data
Waters Corporation (WAT) Areas to Watch (4)
Earnings declining -3.10%, profits shrinking
Very expensive at 9.4x annual revenue
Very expensive at 11.4x book value
Modest revenue growth at 6.80%
Supporting Valuation Data
Waters Corporation (WAT) Detailed Analysis Report
Overall Assessment
This company scores 60/100 in our Smart Analysis, earning a C grade. Out of 10 metrics analyzed, 6 register as strengths (avg 9.2/10) while 4 fall into concern territory (avg 2.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Return on Equity, Operating Margin, Profit Margin. Valuation metrics including PEG Ratio (1.25) suggest the stock is attractively priced. Profitability is solid with Return on Equity at 29.30%, Operating Margin at 33.80%, Profit Margin at 20.30%.
The Bear Case
The primary concerns are EPS Growth, Price/Sales, Price/Book. Some valuation metrics including Price/Sales (9.37), Price/Book (11.45) suggest expensive pricing. Growth concerns include Revenue Growth at 6.80%, EPS Growth at -3.10%, which may limit upside.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether EPS Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 29.30% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at 6.80% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. The weight of evidence leans positive, with more strengths than concerns. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Return on Equity, Operating Margin) and negatives (EPS Growth, Price/Sales). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
WAT Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
WAT's Price-to-Sales ratio of 9.37x trades 89% above its historical average of 4.95x (97th percentile), historically expensive. The current valuation is 5% below its historical high of 9.9x set in Mar 2026, and 328% above its historical low of 2.19x in Feb 2009.
WallStSmart Analysis Synopsis
Data-driven financial summary for Waters Corporation (WAT) · HEALTHCARE › DIAGNOSTICS & RESEARCH
The Big Picture
Waters Corporation is a mature, profitable business with steady cash generation. Revenue reached 3.2B with 7% growth year-over-year. Profit margins are strong at 20.3%, reflecting pricing power and operational efficiency.
Key Findings
ROE of 29.3% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Profit margin of 20.3% and operating margin of 33.8% demonstrate strong pricing power and operational efficiency.
What to Watch Next
Sector dynamics: monitor DIAGNOSTICS & RESEARCH industry trends, competitive moves, and regulatory changes that could impact Waters Corporation.
Bottom Line
Waters Corporation is a well-established business delivering consistent profitability with 20.3% margins. The growth phase may be slowing, but strong cash generation and operational efficiency make it suitable for investors seeking reliability over excitement.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Waters Corporation(WAT)
NYSE
HEALTHCARE
DIAGNOSTICS & RESEARCH
USA
Waters Corporation is a publicly traded Analytical Laboratory instrument and software company headquartered in Milford, Massachusetts.